JP2008297238A - Water-in-oil emulsion type powder-containing external preparation for skin - Google Patents
Water-in-oil emulsion type powder-containing external preparation for skin Download PDFInfo
- Publication number
- JP2008297238A JP2008297238A JP2007144519A JP2007144519A JP2008297238A JP 2008297238 A JP2008297238 A JP 2008297238A JP 2007144519 A JP2007144519 A JP 2007144519A JP 2007144519 A JP2007144519 A JP 2007144519A JP 2008297238 A JP2008297238 A JP 2008297238A
- Authority
- JP
- Japan
- Prior art keywords
- powder
- water
- external preparation
- skin
- oil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000843 powder Substances 0.000 title claims abstract description 95
- 238000002360 preparation method Methods 0.000 title claims abstract description 48
- 239000007762 w/o emulsion Substances 0.000 title abstract description 5
- ULQISTXYYBZJSJ-UHFFFAOYSA-N 12-hydroxyoctadecanoic acid Chemical compound CCCCCCC(O)CCCCCCCCCCC(O)=O ULQISTXYYBZJSJ-UHFFFAOYSA-N 0.000 claims abstract description 23
- 229920001296 polysiloxane Polymers 0.000 claims abstract description 22
- 239000002253 acid Substances 0.000 claims abstract description 20
- 150000003839 salts Chemical class 0.000 claims abstract description 20
- 229910052782 aluminium Inorganic materials 0.000 claims abstract description 14
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical group [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims abstract description 13
- 229940114072 12-hydroxystearic acid Drugs 0.000 claims abstract description 12
- 239000011247 coating layer Substances 0.000 claims abstract description 12
- 229920000578 graft copolymer Polymers 0.000 claims abstract description 9
- 230000001804 emulsifying effect Effects 0.000 claims abstract description 6
- 239000002734 clay mineral Substances 0.000 claims abstract description 4
- 229940071085 lauroyl glutamate Drugs 0.000 claims abstract description 4
- 229940071136 stearoyl glutamate Drugs 0.000 claims abstract description 4
- 239000003921 oil Substances 0.000 claims description 46
- 239000003995 emulsifying agent Substances 0.000 claims description 27
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 24
- 239000000194 fatty acid Substances 0.000 claims description 24
- 229930195729 fatty acid Natural products 0.000 claims description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- 150000004665 fatty acids Chemical class 0.000 claims description 14
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 claims description 12
- 210000002374 sebum Anatomy 0.000 claims description 12
- 230000000694 effects Effects 0.000 claims description 11
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical group O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 claims description 10
- 229910052588 hydroxylapatite Inorganic materials 0.000 claims description 9
- 229910052901 montmorillonite Inorganic materials 0.000 claims description 9
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 claims description 9
- 230000009471 action Effects 0.000 claims description 7
- 239000003795 chemical substances by application Substances 0.000 claims description 6
- 229910052725 zinc Inorganic materials 0.000 claims description 6
- 239000011701 zinc Substances 0.000 claims description 6
- 239000011787 zinc oxide Substances 0.000 claims description 6
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 5
- 238000000034 method Methods 0.000 abstract description 19
- 239000011248 coating agent Substances 0.000 abstract description 10
- 238000000576 coating method Methods 0.000 abstract description 10
- -1 isostearoyl group Chemical group 0.000 description 37
- 239000002537 cosmetic Substances 0.000 description 31
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 17
- 238000004519 manufacturing process Methods 0.000 description 14
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 13
- 235000019198 oils Nutrition 0.000 description 12
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 11
- 239000000203 mixture Substances 0.000 description 11
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 10
- 238000012423 maintenance Methods 0.000 description 10
- 238000012360 testing method Methods 0.000 description 9
- 239000012071 phase Substances 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 239000004408 titanium dioxide Substances 0.000 description 8
- 239000006096 absorbing agent Substances 0.000 description 7
- 239000007864 aqueous solution Substances 0.000 description 7
- 239000004359 castor oil Substances 0.000 description 7
- 235000019438 castor oil Nutrition 0.000 description 7
- 238000009472 formulation Methods 0.000 description 7
- 235000011187 glycerol Nutrition 0.000 description 7
- 229960005150 glycerol Drugs 0.000 description 7
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 7
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 6
- BRGKNMJAFJDJNH-QVAZYVOZSA-H dialuminum;(2s)-2-(octadecanoylamino)pentanedioate Chemical compound [Al+3].[Al+3].CCCCCCCCCCCCCCCCCC(=O)N[C@H](C([O-])=O)CCC([O-])=O.CCCCCCCCCCCCCCCCCC(=O)N[C@H](C([O-])=O)CCC([O-])=O.CCCCCCCCCCCCCCCCCC(=O)N[C@H](C([O-])=O)CCC([O-])=O BRGKNMJAFJDJNH-QVAZYVOZSA-H 0.000 description 6
- POPACFLNWGUDSR-UHFFFAOYSA-N methoxy(trimethyl)silane Chemical compound CO[Si](C)(C)C POPACFLNWGUDSR-UHFFFAOYSA-N 0.000 description 6
- 229920000642 polymer Polymers 0.000 description 6
- 239000000454 talc Substances 0.000 description 6
- 229910052623 talc Inorganic materials 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 239000004166 Lanolin Substances 0.000 description 4
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 4
- 239000003086 colorant Substances 0.000 description 4
- 235000019388 lanolin Nutrition 0.000 description 4
- 229940039717 lanolin Drugs 0.000 description 4
- 229910052751 metal Inorganic materials 0.000 description 4
- 239000002184 metal Substances 0.000 description 4
- 239000010445 mica Substances 0.000 description 4
- 229910052618 mica group Inorganic materials 0.000 description 4
- 230000003287 optical effect Effects 0.000 description 4
- 239000000344 soap Substances 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 238000004381 surface treatment Methods 0.000 description 4
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 3
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 3
- 229960003237 betaine Drugs 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 239000002131 composite material Substances 0.000 description 3
- GMGONJRHVPHAPD-UCLFVTEUSA-H dialuminum;(2s)-2-(dodecanoylamino)pentanedioate Chemical group [Al+3].[Al+3].CCCCCCCCCCCC(=O)N[C@H](C([O-])=O)CCC([O-])=O.CCCCCCCCCCCC(=O)N[C@H](C([O-])=O)CCC([O-])=O.CCCCCCCCCCCC(=O)N[C@H](C([O-])=O)CCC([O-])=O GMGONJRHVPHAPD-UCLFVTEUSA-H 0.000 description 3
- 239000006185 dispersion Substances 0.000 description 3
- 239000002552 dosage form Substances 0.000 description 3
- 238000004945 emulsification Methods 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 3
- 238000006884 silylation reaction Methods 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000000600 sorbitol Substances 0.000 description 3
- 229960002920 sorbitol Drugs 0.000 description 3
- 210000004243 sweat Anatomy 0.000 description 3
- 150000003722 vitamin derivatives Chemical class 0.000 description 3
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 3
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 2
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 2
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- 239000004386 Erythritol Substances 0.000 description 2
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 2
- JWGGSJFIGIGFSQ-UHFFFAOYSA-N N-dodecanoylglycine Chemical compound CCCCCCCCCCCC(=O)NCC(O)=O JWGGSJFIGIGFSQ-UHFFFAOYSA-N 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 229920001214 Polysorbate 60 Polymers 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 229930003779 Vitamin B12 Natural products 0.000 description 2
- 229930003316 Vitamin D Natural products 0.000 description 2
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 2
- 125000002252 acyl group Chemical group 0.000 description 2
- 150000005215 alkyl ethers Chemical class 0.000 description 2
- 239000002280 amphoteric surfactant Substances 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- 235000013871 bee wax Nutrition 0.000 description 2
- 239000012166 beeswax Substances 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- ZCCIPPOKBCJFDN-UHFFFAOYSA-N calcium nitrate Chemical compound [Ca+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O ZCCIPPOKBCJFDN-UHFFFAOYSA-N 0.000 description 2
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 2
- 239000003240 coconut oil Substances 0.000 description 2
- 235000019864 coconut oil Nutrition 0.000 description 2
- 229940105990 diglycerin Drugs 0.000 description 2
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 2
- 235000019414 erythritol Nutrition 0.000 description 2
- 229940009714 erythritol Drugs 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 2
- 229940119170 jojoba wax Drugs 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- 239000000787 lecithin Substances 0.000 description 2
- 235000010445 lecithin Nutrition 0.000 description 2
- 229940067606 lecithin Drugs 0.000 description 2
- 239000000845 maltitol Substances 0.000 description 2
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 2
- 235000010449 maltitol Nutrition 0.000 description 2
- 229940035436 maltitol Drugs 0.000 description 2
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 2
- 239000007764 o/w emulsion Substances 0.000 description 2
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- XOJVVFBFDXDTEG-UHFFFAOYSA-N pristane Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)C XOJVVFBFDXDTEG-UHFFFAOYSA-N 0.000 description 2
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 2
- MMXZSJMASHPLLR-UHFFFAOYSA-N pyrroloquinoline quinone Chemical compound C12=C(C(O)=O)C=C(C(O)=O)N=C2C(=O)C(=O)C2=C1NC(C(=O)O)=C2 MMXZSJMASHPLLR-UHFFFAOYSA-N 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 235000010356 sorbitol Nutrition 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 150000005846 sugar alcohols Polymers 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
- DZKDPOPGYFUOGI-UHFFFAOYSA-N tungsten(iv) oxide Chemical compound O=[W]=O DZKDPOPGYFUOGI-UHFFFAOYSA-N 0.000 description 2
- 235000019163 vitamin B12 Nutrition 0.000 description 2
- 239000011715 vitamin B12 Substances 0.000 description 2
- 235000019166 vitamin D Nutrition 0.000 description 2
- 239000011710 vitamin D Substances 0.000 description 2
- 229940046008 vitamin d Drugs 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- ONDPHDOFVYQSGI-UHFFFAOYSA-N zinc nitrate Chemical compound [Zn+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O ONDPHDOFVYQSGI-UHFFFAOYSA-N 0.000 description 2
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 1
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- BNGXYYYYKUGPPF-UHFFFAOYSA-M (3-methylphenyl)methyl-triphenylphosphanium;chloride Chemical compound [Cl-].CC1=CC=CC(C[P+](C=2C=CC=CC=2)(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1 BNGXYYYYKUGPPF-UHFFFAOYSA-M 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- PSBDWGZCVUAZQS-UHFFFAOYSA-N (dimethylsulfonio)acetate Chemical compound C[S+](C)CC([O-])=O PSBDWGZCVUAZQS-UHFFFAOYSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 1
- 229940015975 1,2-hexanediol Drugs 0.000 description 1
- 229940031723 1,2-octanediol Drugs 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- RKJGFHYCZPZJPE-UHFFFAOYSA-N 2,2-bis(16-methylheptadecanoyloxymethyl)butyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(CC)(COC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C RKJGFHYCZPZJPE-UHFFFAOYSA-N 0.000 description 1
- XFOQWQKDSMIPHT-UHFFFAOYSA-N 2,3-dichloro-6-(trifluoromethyl)pyridine Chemical compound FC(F)(F)C1=CC=C(Cl)C(Cl)=N1 XFOQWQKDSMIPHT-UHFFFAOYSA-N 0.000 description 1
- FKOKUHFZNIUSLW-UHFFFAOYSA-N 2-Hydroxypropyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(C)O FKOKUHFZNIUSLW-UHFFFAOYSA-N 0.000 description 1
- NCLNAHJFXIKYBY-UHFFFAOYSA-N 2-hexyldecyl 16-methylheptadecanoate Chemical compound CCCCCCCCC(CCCCCC)COC(=O)CCCCCCCCCCCCCCC(C)C NCLNAHJFXIKYBY-UHFFFAOYSA-N 0.000 description 1
- MUHFRORXWCGZGE-KTKRTIGZSA-N 2-hydroxyethyl (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCCO MUHFRORXWCGZGE-KTKRTIGZSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- XPFCZYUVICHKDS-UHFFFAOYSA-N 3-methylbutane-1,3-diol Chemical compound CC(C)(O)CCO XPFCZYUVICHKDS-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- HBTAOSGHCXUEKI-UHFFFAOYSA-N 4-chloro-n,n-dimethyl-3-nitrobenzenesulfonamide Chemical compound CN(C)S(=O)(=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 HBTAOSGHCXUEKI-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- 239000005696 Diammonium phosphate Substances 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical class [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- DCXXMTOCNZCJGO-UHFFFAOYSA-N Glycerol trioctadecanoate Natural products CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- RVSTWRHIGKXTLG-UHFFFAOYSA-N Pangamic acid Natural products CC(C)N(C(C)C)C(N(C(C)C)C(C)C)C(=O)OCC(O)C(O)C(O)C(O)C(O)=O RVSTWRHIGKXTLG-UHFFFAOYSA-N 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- DHXVGJBLRPWPCS-UHFFFAOYSA-N Tetrahydropyran Chemical compound C1CCOCC1 DHXVGJBLRPWPCS-UHFFFAOYSA-N 0.000 description 1
- 229920002359 Tetronic® Polymers 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- LXNHXLLTXMVWPM-UHFFFAOYSA-N Vitamin B6 Natural products CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 1
- 229930003756 Vitamin B7 Natural products 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- UDRYFKCHZFVZGJ-UHFFFAOYSA-N [5-hexadecanoyloxy-4-(hexadecanoyloxymethyl)-6-methylpyridin-3-yl]methyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC1=CN=C(C)C(OC(=O)CCCCCCCCCCCCCCC)=C1COC(=O)CCCCCCCCCCCCCCC UDRYFKCHZFVZGJ-UHFFFAOYSA-N 0.000 description 1
- RJDOZRNNYVAULJ-UHFFFAOYSA-L [O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[F-].[F-].[Mg++].[Mg++].[Mg++].[Al+3].[Si+4].[Si+4].[Si+4].[K+] Chemical compound [O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[F-].[F-].[Mg++].[Mg++].[Mg++].[Al+3].[Si+4].[Si+4].[Si+4].[K+] RJDOZRNNYVAULJ-UHFFFAOYSA-L 0.000 description 1
- XNYQNWHBYNTXMF-UQKRIMTDSA-L [Zn+2].C(CCCCCCCCCCC)(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-] Chemical compound [Zn+2].C(CCCCCCCCCCC)(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-] XNYQNWHBYNTXMF-UQKRIMTDSA-L 0.000 description 1
- 229940022663 acetate Drugs 0.000 description 1
- 238000010306 acid treatment Methods 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- CEGOLXSVJUTHNZ-UHFFFAOYSA-K aluminium tristearate Chemical compound [Al+3].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CEGOLXSVJUTHNZ-UHFFFAOYSA-K 0.000 description 1
- 229940063655 aluminum stearate Drugs 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- 239000010426 asphalt Substances 0.000 description 1
- 239000012752 auxiliary agent Substances 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- IRERQBUNZFJFGC-UHFFFAOYSA-L azure blue Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[S-]S[S-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-] IRERQBUNZFJFGC-UHFFFAOYSA-L 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- 150000008316 benzisoxazoles Chemical class 0.000 description 1
- 125000005605 benzo group Chemical group 0.000 description 1
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 1
- 239000012965 benzophenone Substances 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229940073609 bismuth oxychloride Drugs 0.000 description 1
- 235000012745 brilliant blue FCF Nutrition 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- KHAVLLBUVKBTBG-UHFFFAOYSA-N caproleic acid Natural products OC(=O)CCCCCCCC=C KHAVLLBUVKBTBG-UHFFFAOYSA-N 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- JBTHDAVBDKKSRW-UHFFFAOYSA-N chembl1552233 Chemical compound CC1=CC(C)=CC=C1N=NC1=C(O)C=CC2=CC=CC=C12 JBTHDAVBDKKSRW-UHFFFAOYSA-N 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 229910000428 cobalt oxide Inorganic materials 0.000 description 1
- IVMYJDGYRUAWML-UHFFFAOYSA-N cobalt(ii) oxide Chemical compound [Co]=O IVMYJDGYRUAWML-UHFFFAOYSA-N 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- MNNHAPBLZZVQHP-UHFFFAOYSA-N diammonium hydrogen phosphate Chemical compound [NH4+].[NH4+].OP([O-])([O-])=O MNNHAPBLZZVQHP-UHFFFAOYSA-N 0.000 description 1
- 229910000388 diammonium phosphate Inorganic materials 0.000 description 1
- 235000019838 diammonium phosphate Nutrition 0.000 description 1
- 150000005690 diesters Chemical class 0.000 description 1
- 229940031578 diisopropyl adipate Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- VJHINFRRDQUWOJ-UHFFFAOYSA-N dioctyl sebacate Chemical compound CCCCC(CC)COC(=O)CCCCCCCCC(=O)OCC(CC)CCCC VJHINFRRDQUWOJ-UHFFFAOYSA-N 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- VPWFPZBFBFHIIL-UHFFFAOYSA-L disodium 4-[(4-methyl-2-sulfophenyl)diazenyl]-3-oxidonaphthalene-2-carboxylate Chemical compound [Na+].[Na+].[O-]S(=O)(=O)C1=CC(C)=CC=C1N=NC1=C(O)C(C([O-])=O)=CC2=CC=CC=C12 VPWFPZBFBFHIIL-UHFFFAOYSA-L 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- SYELZBGXAIXKHU-UHFFFAOYSA-N dodecyldimethylamine N-oxide Chemical compound CCCCCCCCCCCC[N+](C)(C)[O-] SYELZBGXAIXKHU-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000000806 elastomer Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000010696 ester oil Substances 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 235000010382 gamma-tocopherol Nutrition 0.000 description 1
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 125000000291 glutamic acid group Chemical group N[C@@H](CCC(O)=O)C(=O)* 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- KWLMIXQRALPRBC-UHFFFAOYSA-L hectorite Chemical class [Li+].[OH-].[OH-].[Na+].[Mg+2].O1[Si]2([O-])O[Si]1([O-])O[Si]([O-])(O1)O[Si]1([O-])O2 KWLMIXQRALPRBC-UHFFFAOYSA-L 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- OIKBVOIOVNEVJR-UHFFFAOYSA-N hexadecyl 6-methylheptanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCC(C)C OIKBVOIOVNEVJR-UHFFFAOYSA-N 0.000 description 1
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 1
- TXGJTWACJNYNOJ-UHFFFAOYSA-N hexane-2,4-diol Chemical compound CCC(O)CC(C)O TXGJTWACJNYNOJ-UHFFFAOYSA-N 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical compound C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000001023 inorganic pigment Substances 0.000 description 1
- WTFXARWRTYJXII-UHFFFAOYSA-N iron(2+);iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+2].[Fe+3].[Fe+3] WTFXARWRTYJXII-UHFFFAOYSA-N 0.000 description 1
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- KFZMGEQAYNKOFK-UHFFFAOYSA-N isopropyl alcohol Natural products CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 238000004898 kneading Methods 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229940033355 lauric acid Drugs 0.000 description 1
- 125000000400 lauroyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- 125000001419 myristoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940043348 myristyl alcohol Drugs 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- SLCVBVWXLSEKPL-UHFFFAOYSA-N neopentyl glycol Chemical compound OCC(C)(C)CO SLCVBVWXLSEKPL-UHFFFAOYSA-N 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- HMMGMWAXVFQUOA-UHFFFAOYSA-N octamethylcyclotetrasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 HMMGMWAXVFQUOA-UHFFFAOYSA-N 0.000 description 1
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 125000002811 oleoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- BWOROQSFKKODDR-UHFFFAOYSA-N oxobismuth;hydrochloride Chemical compound Cl.[Bi]=O BWOROQSFKKODDR-UHFFFAOYSA-N 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 229940098695 palmitic acid Drugs 0.000 description 1
- 125000001312 palmitoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- ZQTHOIGMSJMBLM-BUJSFMDZSA-N pangamic acid Chemical compound CN(C)CC(=O)OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O ZQTHOIGMSJMBLM-BUJSFMDZSA-N 0.000 description 1
- 108700024047 pangamic acid Proteins 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920001281 polyalkylene Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920000223 polyglycerol Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- ONQDVAFWWYYXHM-UHFFFAOYSA-M potassium lauryl sulfate Chemical compound [K+].CCCCCCCCCCCCOS([O-])(=O)=O ONQDVAFWWYYXHM-UHFFFAOYSA-M 0.000 description 1
- 229940116985 potassium lauryl sulfate Drugs 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 229940095050 propylene Drugs 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 229940093625 propylene glycol monostearate Drugs 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 150000003856 quaternary ammonium compounds Chemical class 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 229910000077 silane Inorganic materials 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- BTURAGWYSMTVOW-UHFFFAOYSA-M sodium dodecanoate Chemical compound [Na+].CCCCCCCCCCCC([O-])=O BTURAGWYSMTVOW-UHFFFAOYSA-M 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 229940082004 sodium laurate Drugs 0.000 description 1
- 229940045870 sodium palmitate Drugs 0.000 description 1
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 description 1
- IWIUXJGIDSGWDN-UQKRIMTDSA-M sodium;(2s)-2-(dodecanoylamino)pentanedioate;hydron Chemical compound [Na+].CCCCCCCCCCCC(=O)N[C@H](C([O-])=O)CCC(O)=O IWIUXJGIDSGWDN-UQKRIMTDSA-M 0.000 description 1
- HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 description 1
- GGXKEBACDBNFAF-UHFFFAOYSA-M sodium;hexadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCC([O-])=O GGXKEBACDBNFAF-UHFFFAOYSA-M 0.000 description 1
- QKHBMQWPOUUMQZ-BDQAORGHSA-M sodium;hydron;(2s)-2-(octadecanoylamino)pentanedioate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC(=O)N[C@H](C(O)=O)CCC([O-])=O QKHBMQWPOUUMQZ-BDQAORGHSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000001593 sorbitan monooleate Substances 0.000 description 1
- 235000011069 sorbitan monooleate Nutrition 0.000 description 1
- 229940035049 sorbitan monooleate Drugs 0.000 description 1
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 229960004274 stearic acid Drugs 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 125000003696 stearoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 229940117986 sulfobetaine Drugs 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 150000003852 triazoles Chemical class 0.000 description 1
- PDSVZUAJOIQXRK-UHFFFAOYSA-N trimethyl(octadecyl)azanium Chemical compound CCCCCCCCCCCCCCCCCC[N+](C)(C)C PDSVZUAJOIQXRK-UHFFFAOYSA-N 0.000 description 1
- UJMBCXLDXJUMFB-UHFFFAOYSA-K trisodium;5-oxo-1-(4-sulfonatophenyl)-4-[(4-sulfonatophenyl)diazenyl]-4h-pyrazole-3-carboxylate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)C1=NN(C=2C=CC(=CC=2)S([O-])(=O)=O)C(=O)C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 UJMBCXLDXJUMFB-UHFFFAOYSA-K 0.000 description 1
- 229960002703 undecylenic acid Drugs 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000011912 vitamin B7 Nutrition 0.000 description 1
- 239000011735 vitamin B7 Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 150000003751 zinc Chemical class 0.000 description 1
- QVLLDPBOWNCACO-BDQAORGHSA-L zinc;(2s)-2-(octadecanoylamino)pentanedioate Chemical compound [Zn+2].CCCCCCCCCCCCCCCCCC(=O)N[C@H](C([O-])=O)CCC([O-])=O QVLLDPBOWNCACO-BDQAORGHSA-L 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 239000002478 γ-tocopherol Substances 0.000 description 1
- QUEDXNHFTDJVIY-DQCZWYHMSA-N γ-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-DQCZWYHMSA-N 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
本発明は、皮膚外用剤に関し、更に詳細には、化粧料などに好適な、粉体を含有する皮膚外用剤に関する。 The present invention relates to an external preparation for skin, and more particularly to an external preparation for skin containing a powder suitable for cosmetics and the like.
メークアップ化粧料は、粉体などの色剤の光学効果を利用して、顔などの皮膚の好ましくない部分を見えにくくし、好印象を誘導しやすい部位を強調してみせる効果を有する化粧料である。この為、粉体などの色剤の効果が如実に発現することから、メークアップ化粧料の化粧膜のゆらぎはたちまち、メークアップ効果の著しい低下につながることが少なくない。メークアップ化粧料に於いては、基礎化粧料以上に、その化粧仕上がり、皮膚との接着性の維持が要求されていると言える。言い換えれば、メークアップ化粧料における化粧持ちの良さは、メークアップ化粧直後の仕上がりの美しさと同程度に重要な品質を定める要素となっている。この為、メークアップ化粧料の技術者は、化粧持ちの向上のために多くの努力を捧げてきている。 Makeup cosmetics are cosmetics that make use of the optical effect of colorants such as powders, making it difficult to see unfavorable parts of the skin such as the face, and highlighting areas that are likely to induce good impressions. It is. For this reason, since the effect of the colorant such as powder is clearly manifested, fluctuations in the makeup film of the makeup cosmetics are often led to a significant decrease in the makeup effect. In the makeup cosmetics, it can be said that more than the basic cosmetics, the makeup finish and the maintenance of the adhesion to the skin are required. In other words, the goodness of makeup in makeup cosmetics is an element that defines quality as important as the beauty of the finish immediately after makeup makeup. For this reason, makeup cosmetics engineers have devoted a lot of effort to improving makeup.
この様な努力の成果、一つの重要な基礎技術として、液状油性成分の含有量の多い油中水乳化剤形に、粉体を配合する技術が挙げられる。この技術により、固形脂によって、色剤の光学効果が損なわれるのを防ぐと同時に、化粧膜の汗などの水性成分による崩壊を防ぐことが出来、これらに起因する化粧崩れが減少し、化粧持ちが向上した。この様な油中水乳化系の形成は、使用する界面活性剤に依存性が高く、例えば、アクリル−シリコーン系グラフト共重合体の作る高分子油性構造を利用する方法(例えば、特許文献1、特許文献2、特許文献3、特許文献4、特許文献5を参照)、12−ヒドロキシステアリン酸或いは12−ヒドロキシステアリン酸ポリマーの作るゲル構造を利用する方法(例えば、特許文献6、特許文献7、特許文献8を参照)、4級アンモニウム化合物で有機変性したモンモリロナイトを利用する方法(例えば、特許文献9)等が存する。この様な油中水乳化剤形に粉体を均一に分散させるためには、粉体自身も親油性の表面処理を施されることが要求されるが、この様な親油性の表面処理としては、通常はハイドロジェンメチルポリシロキサンの焼付処理や、アルキルアルコキシシラン等によるシランカップリング処理が行われている。しかしながら、この様な親油化粉体を含有する油中水乳化剤形の皮膚外用剤が皮膚上に形成する被膜は、汗などの水性成分に対する被膜維持性は高いものの、皮脂などの生体由来油性成分に対しては被膜そのものの構造が壊されやすく、この傾向は、粉体の表面が親油化処理されていればいるほど著しい傾向にあり、この様なメカニズムによる新たな化粧崩れが生じていた。 As a result of such efforts, as one important basic technique, there is a technique of blending powder into a water-in-oil emulsifier form having a high content of liquid oily components. With this technology, it is possible to prevent the optical effect of the colorant from being damaged by solid fat, and at the same time to prevent the cosmetic film from collapsing due to aqueous components such as sweat. Improved. Formation of such a water-in-oil emulsion system is highly dependent on the surfactant to be used. For example, a method using a polymer oily structure formed by an acrylic-silicone graft copolymer (for example, Patent Document 1, Patent Document 2, Patent Document 3, Patent Document 4, and Patent Document 5), a method using a gel structure made of 12-hydroxystearic acid or 12-hydroxystearic acid polymer (for example, Patent Document 6, Patent Document 7, There is a method using montmorillonite organically modified with a quaternary ammonium compound (for example, Patent Document 9). In order to uniformly disperse the powder in such a water-in-oil emulsifier form, it is required that the powder itself be subjected to a lipophilic surface treatment. As such a lipophilic surface treatment, Usually, baking treatment of hydrogenmethylpolysiloxane or silane coupling treatment with alkylalkoxysilane or the like is performed. However, the film formed on the skin by a water-in-oil emulsifier type skin external preparation containing such a lipophilic powder has a high film maintenance property against aqueous components such as sweat, but it is derived from biological oil such as sebum. For the ingredients, the structure of the film itself is easily broken, and this tendency tends to become more prominent as the surface of the powder is oleophilicized. It was.
生体由来の脂質、特に、脂肪酸が化粧崩れに大きな影響を与えることは既に知られており、この様な脂肪酸をトラップする粉体として、層間に金属イオンをクラスレートした粘土鉱物(例えば、特許文献10を参照)やヒドロキシアパタイトで被覆した粉体(例えば、特許文献11、特許文献12を参照)等が知られているが、単にこの様な皮脂をトラップする粉体を粉体含有油中水乳化剤形の皮膚外用剤に配合しても、皮膚との接着維持性は向上されない。これは皮膜中を粉体が容易に移動するためと考えられている。 It is already known that living body-derived lipids, especially fatty acids, have a significant effect on cosmetic disintegration, and clay minerals clad with metal ions between layers as powders for trapping such fatty acids (for example, patent documents) 10) and powder coated with hydroxyapatite (see, for example, Patent Document 11 and Patent Document 12) are known. Simply, powder containing such sebum is used as powder-containing water-in-oil. Even if it is blended into an emulsifier-type skin external preparation, adhesion maintenance with the skin is not improved. This is considered because the powder easily moves in the film.
一方、粉体の表面をN−アシルアミノ酸アルミニウム塩等のN−アシルアミノ酸金属塩で被覆する技術は既に知られており(例えば、特許文献13、特許文献14、特許文献15を参照)、湿状態で配合し、使用時は親水性の被膜であり、塗布、乾燥後疎水性の被膜に変わるような化粧料の設計などに用いられていたが、この様な粉体を水を包含しない状態で油中水剤形に含有させることは行われていなかった。 On the other hand, a technique for coating the surface of a powder with an N-acylamino acid metal salt such as an N-acylamino acid aluminum salt is already known (see, for example, Patent Document 13, Patent Document 14, and Patent Document 15). It was formulated in a state and it was a hydrophilic film when used, and it was used for cosmetics design that changed to a hydrophobic film after application and drying, but such powder does not contain water However, it was not included in the water-in-oil dosage form.
N−アシルアミノ酸塩を含む被覆層を有する粉体を5〜50質量%含有する油中水剤形の皮膚外用剤は全く知られていなかったし、この様な構成の皮膚外用剤が優れた皮膚との接着維持性を有することも全く知られていなかった。 No skin external preparation in the form of a water-in-oil formulation containing 5 to 50% by mass of a powder having a coating layer containing an N-acylamino acid salt has been known, and the skin external preparation having such a structure is excellent. It has not been known at all that it has adhesion maintenance with the skin.
本発明は、この様な状況下為されたものであり、粉体を含有する油中水乳化剤形の皮膚外用剤において、その皮膚外用剤が皮膚上に形成する皮膜の接着維持性を向上せしめることを課題とする。 The present invention has been made under such circumstances, and in a skin external preparation in the form of a water-in-oil emulsifier containing powder, the skin external preparation improves the adhesion maintenance of the film formed on the skin. This is the issue.
この様な状況に鑑みて、本発明者らは、粉体を含有する油中水乳化剤形の皮膚外用剤において、その皮膚外用剤が皮膚上に形成する皮膜の接着維持性を向上せしめる技術を求めて、鋭意研究努力を重ねた結果、含有させる粉体として、N−アシルアミノ酸塩を含む被覆層を有する粉体を用いることにより、この様な向上が図れることを見いだし、発明を完成させるに至った。即ち、本発明は以下に示すとおりである。
(1)N−アシルアミノ酸塩を含む被覆層を有する粉体を5〜50質量%含有することを特徴とする、油中水乳化剤形の皮膚外用剤。
(2)前記N−アシルアミノ酸塩はN−ラウロイルグルタミン酸アルミニウム及び/又はN−ステアロイルグルタミン酸アルミニウムであることを特徴とする、(1)に記載の油中水乳化剤形の皮膚外用剤。
(3)乳化成分として、有機変性粘土鉱物を含有することを特徴とする、(1)又は(2)に記載の油中水乳化剤形の皮膚外用剤。
(4)アクリル−シリコーン系グラフト共重合体を含有することを特徴とする、(1)〜(3)何れか1項に記載の油中水乳化剤形の皮膚外用剤。
(5)12−ヒドロキシステアリン酸を含有することを特徴とする、(1)〜(4)何れか1項に記載の油中水乳化剤形の皮膚外用剤。
(6)ポリ(12−ヒドロキシステアリン酸)を含有することを特徴とする、(1)〜(5)何れか1項に記載の油中水乳化剤形の皮膚外用剤。
(7)更に、皮脂中の脂肪酸をトラップする作用を有する粉体を0.01〜5質量%含有することを特徴とする、(1)〜(6)何れか1項に記載の油中水乳化剤形の皮膚外用剤。
(8)皮脂中の脂肪酸をトラップする作用を有する粉体は、亜鉛及び/又はアルミニウムをインターカレートしたモンモリロナイト、酸化亜鉛及びヒドキシアパタイト被覆粉体から選択されるものである、(7)に記載の油中水乳化剤形の皮膚外用剤。
In view of such a situation, the present inventors have developed a technique for improving the adhesion maintenance property of a film formed on the skin by the skin external preparation in a water-in-oil emulsifier type skin external preparation containing powder. As a result of intensive research efforts, the inventors have found that such powder can be improved by using a powder having a coating layer containing an N-acylamino acid salt as a powder to be contained, and the invention is completed. It came. That is, the present invention is as follows.
(1) A skin external preparation in the form of a water-in-oil emulsifier comprising 5 to 50% by mass of a powder having a coating layer containing an N-acylamino acid salt.
(2) The skin external preparation in the form of a water-in-oil emulsifier according to (1), wherein the N-acylamino acid salt is aluminum N-lauroylglutamate and / or aluminum N-stearoylglutamate.
(3) The skin external preparation in the form of a water-in-oil emulsifier according to (1) or (2), which contains an organically modified clay mineral as an emulsifying component.
(4) The skin external preparation in the form of a water-in-oil emulsifier according to any one of (1) to (3), which contains an acrylic-silicone graft copolymer.
(5) The skin external preparation in the form of a water-in-oil emulsifier according to any one of (1) to (4), comprising 12-hydroxystearic acid.
(6) The skin external preparation in the form of a water-in-oil emulsifier according to any one of (1) to (5), comprising poly (12-hydroxystearic acid).
(7) The water-in-oil according to any one of (1) to (6), further comprising 0.01 to 5% by mass of a powder having an action of trapping fatty acids in sebum. Emulsifier type skin external preparation.
(8) The powder having an action of trapping fatty acids in sebum is selected from montmorillonite intercalated with zinc and / or aluminum, zinc oxide, and hydroxyapatite-coated powder. The skin external preparation in the form of a water-in-oil emulsifier as described.
本発明のよれば、粉体を含有する油中水乳化剤形の皮膚外用剤において、その皮膚外用剤が皮膚上に形成する皮膜の接着維持性を向上せしめることが出来る。 ADVANTAGE OF THE INVENTION According to this invention, in the skin external preparation of the water-in-oil emulsifier form containing powder, the adhesive maintenance property of the film | membrane which the skin external preparation forms on skin can be improved.
(1)本発明の皮膚外用剤の必須成分であるN−アシルアミノ酸塩を含む被覆層を有する粉体
本発明の皮膚外用剤は、油中水剤形であって、N−アシルアミノ酸塩を含む被覆層を有する粉体を必須成分として含有することを特徴とする。ここで、本発明に言う、油中水乳化剤形とは、最外相が油相である乳化物の総称であり、油相に水相が滴として存在する、W/Oのみならず、油相中に水中油乳化物が滴として存在する、O/W/Oや、油相に水相の滴や水中油乳化物の滴が混在する複合エマルションなども本発明に言う油中水剤形に属する。本発明の皮膚外用剤の必須成分となる粉体は、少なくともN−アシルアミノ酸塩で被覆処理した形態である。該N−アシルアミノ酸塩としては、ラウロイル基、ミリストイル基、パルミトイル基、ステアロイル基、イソステアロイル基、オレオイル基など、アシル基として炭素数10〜30の脂肪族のアシル基を好ましく有し、アミノ酸部分としては、リジン残基乃至はグルタミン酸残基を好ましく有し、塩としては、アルミニウム塩乃至は亜鉛塩を好ましく採用するものである。具体的な例示としては、N−ラウロイルグルタミン酸アルミニウム塩、N−ラウロイルグリシンアルミニウム塩、N−ラウロイルグルタミン酸亜鉛塩、N−ラウロイルグリシン亜鉛塩、N−ステアロイルグルタミン酸アルミニウム塩、N−ステアロイルグルタミン酸亜鉛塩等が好適に例示でき、N−ラウロイルグルタミン酸アルミニウム塩が特に好適に例示できる。この様なN−アシルアミノ酸塩の被覆は、例えば、N−ステアロイルグルタミン酸アルミニウム被覆を例に取れば、N−ステアロイルグルタミン酸ナトリウムの水溶液に粉体を分散させ、しかる後、かかる粉体に、塩化アルミニウムの水溶液を添加し、N−ステアロイルグルタミン酸アルミニウムを粉体上に沈着させればよい。かかる表面処理は、粉体の質量に対し、1〜20%の質量の被覆を行うことが適当である。以下に製造例を示す。
(1) Powder having a coating layer containing an N-acylamino acid salt which is an essential component of the external preparation for skin of the present invention The external preparation for skin of the present invention is a water-in-oil form and contains an N-acylamino acid salt. A powder having a coating layer to be contained is contained as an essential component. Here, the water-in-oil emulsifier form referred to in the present invention is a general term for an emulsion in which the outermost phase is an oil phase, and the water phase is present as droplets in the oil phase. The oil-in-water emulsion forms referred to in the present invention include O / W / O in which oil-in-water emulsions exist as droplets, and composite emulsions in which water-phase drops and oil-in-water emulsion droplets are mixed in the oil phase. Belongs. The powder that is an essential component of the external preparation for skin of the present invention is in a form that is coated with at least an N-acylamino acid salt. The N-acyl amino acid salt preferably has an aliphatic acyl group having 10 to 30 carbon atoms as an acyl group, such as lauroyl group, myristoyl group, palmitoyl group, stearoyl group, isostearoyl group, oleoyl group, and the like. The portion preferably has a lysine residue or a glutamic acid residue, and the salt preferably employs an aluminum salt or a zinc salt. Specific examples include N-lauroyl glutamic acid aluminum salt, N-lauroyl glycine aluminum salt, N-lauroyl glutamic acid zinc salt, N-lauroyl glycine zinc salt, N-stearoyl glutamic acid aluminum salt, N-stearoyl glutamic acid zinc salt and the like. Preferable examples include N-lauroylglutamic acid aluminum salt. For example, in the case of N-acylamino acid aluminum salt coating, for example, N-stearoyl glutamate aluminum coating, powder is dispersed in an aqueous solution of sodium N-stearoyl glutamate, and then aluminum chloride is added to the powder. And an aluminum N-stearoylglutamate solution may be deposited on the powder. The surface treatment is suitably performed with a coating of 1 to 20% of the mass of the powder. Production examples are shown below.
<製造例1>
二酸化チタン100gを500mlの1%N−ラウロイルグルタミン酸ナトリウム水溶液に分散させ、これに125mlの1%塩化アルミニウム水溶液を加え、緩やかに4時間攪拌し、N−ラウロイルグルタミン酸アルミニウムを二酸化チタン表面に沈積させた。反応終了後遠心分離(3000g、10分)して上清を捨て、更に1000mlの水を加え、攪拌した後、遠心分離し、洗浄する作業を3回行った。沈殿した粉体を乾燥させ、擂壊機で壊砕し、1mmヘリングボーンスクリーンを装着したパルベライザーで粉砕し、N−ラウロイルグルタミン酸アルミニウム被覆二酸化チタンである粉体1を得た。
<Production Example 1>
100 g of titanium dioxide was dispersed in 500 ml of 1% sodium N-lauroyl glutamate aqueous solution, 125 ml of 1% aluminum chloride aqueous solution was added thereto, and the mixture was gently stirred for 4 hours to deposit aluminum N-lauroyl glutamate on the titanium dioxide surface. . After completion of the reaction, centrifugation (3000 g, 10 minutes) was performed and the supernatant was discarded. Further, 1000 ml of water was added, stirred, centrifuged, and washed three times. The precipitated powder was dried, crushed with a breaker, and pulverized with a pulverizer equipped with a 1 mm herringbone screen to obtain Powder 1 which was titanium dioxide coated with aluminum N-lauroyl glutamate.
<製造例2>
二酸化チタンをベンガラに代えて、同様に処置し、粉体2を得た。
<Production Example 2>
Powder 2 was obtained in the same manner by replacing titanium dioxide with bengara.
<製造例3>
二酸化チタンを黄色酸化鉄に代えて、同様に処置し、粉体3を得た。
<Production Example 3>
Powder 3 was obtained in the same manner by replacing titanium dioxide with yellow iron oxide.
<製造例4>
二酸化チタンをタルクに代えて、同様に処置し、粉体4を得た。
<Production Example 4>
Powder 4 was obtained by replacing titanium dioxide with talc and treating in the same manner.
斯くして得られたN−アシルアミノ酸塩被覆粉体は、かかる処理に加えて、トリメチルメトキシシランなどのシリル化剤によるシリル化処理を行ったり、ハイドロジェンメチルポリシロキサン焼付処理を行ったり、ステアリン酸アルミニウムのような脂肪酸金属石鹸被覆処理を行ったり、レシチン被覆処理を行ったりすることが出来る。又、逆にトリメチルメトキシシランなどのシリル化剤によるシリル化処理を行ったり、ハイドロジェンメチルポリシロキサン焼付処理を行ったり、ステアリン酸アルミニウムのような脂肪酸金属石鹸被覆処理を行ったり、レシチン被覆処理を行ったりされた被覆粉体に、N−アシルアミノ酸処理を前述のごとに施して用いることも出来る。この様な複合処理粉体も、本発明のN−アシルアミノ酸塩を含有する被覆層を有する粉体に属する。この様な複合処理を行った粉体には、既に市販されているものが存し、かかる市販品を購入して利用することも出来る。この様な市販品としては、例えば、三好化成株式会社製の「SA/NAI−W−10」(トリメチルメトキシシラン処理した後に、N−ステアロイルグルタミン酸アルミニウム処理した二酸化チタン)、「SA/NAI−R−10」(トリメチルメトキシシラン処理した後に、N−ステアロイルグルタミン酸アルミニウム処理した赤色ベンガラ)、「SA/NAI−79−P−10」(トリメチルメトキシシラン処理した後に、N−ステアロイルグルタミン酸アルミニウム処理した紫色ベンガラ)、「SA/NAI−Y−10」(トリメチルメトキシシラン処理した後に、N−ステアロイルグルタミン酸アルミニウム処理した黄色酸化鉄)等が好適に例示できる。 In addition to such treatment, the N-acylamino acid salt-coated powder thus obtained is subjected to silylation treatment with a silylating agent such as trimethylmethoxysilane, hydrogenmethylpolysiloxane baking treatment, stearin A fatty acid metal soap coating treatment such as aluminum oxide or a lecithin coating treatment can be performed. Conversely, silylation treatment with a silylating agent such as trimethylmethoxysilane, hydrogenmethylpolysiloxane baking treatment, fatty acid metal soap coating treatment such as aluminum stearate, lecithin coating treatment, etc. The coated powder thus obtained can be used after being subjected to N-acylamino acid treatment as described above. Such a composite-treated powder also belongs to a powder having a coating layer containing the N-acylamino acid salt of the present invention. Some powders that have been subjected to such a composite treatment are already commercially available, and such commercially available products can be purchased and used. Examples of such commercially available products include “SA / NAI-W-10” (titanium dioxide treated with trimethylmethoxysilane and then treated with aluminum N-stearoylglutamate) manufactured by Miyoshi Kasei Co., Ltd., “SA / NAI-R”. -10 "(red bengara treated with trimethylmethoxysilane and then treated with aluminum N-stearoyl glutamate)," SA / NAI-79-P-10 "(purple bengara treated with trimethylmethoxysilane and treated with aluminum N-stearoylglutamate) ), “SA / NAI-Y-10” (yellow iron oxide treated with trimethylmethoxysilane and then treated with aluminum N-stearoylglutamate), and the like.
本発明の皮膚外用剤における、前記N−アシルアミノ酸塩を含有する被覆層を有する粉体の好ましい含有量は、下限は粉体の光学効果が明確になる5質量%、より好ましくは8質量%であり、上限は粉体分散の可能な上限域である50質量%、より好ましくは45質量%である。本発明の皮膚外用剤では、油中水剤形に該N−アシルアミノ酸塩を含有する被覆層を有する粉体を含有させることにより、適度な親油性の表面特性により、製剤中での良好な分散性を示すと同時に、粉体と皮膚表面の親和性が高いため、容易に油相の動きに応じて粉体が移動することがない。これにより皮膚と組成物との接着維持性が高まり、油中水剤形の特性から、汗などの水性の阻害要因に対しても顕著な抵抗性を示す。 The preferable content of the powder having the coating layer containing the N-acylamino acid salt in the external preparation for skin of the present invention is 5% by mass, more preferably 8% by mass, at which the optical effect of the powder becomes clear at the lower limit. And the upper limit is 50% by mass, more preferably 45% by mass, which is the upper limit of the powder dispersion. In the external preparation for skin according to the present invention, by incorporating a powder having a coating layer containing the N-acylamino acid salt into a water-in-oil dosage form, it has good lipophilic surface characteristics, so that it is excellent in the preparation. While exhibiting dispersibility and high affinity between the powder and the skin surface, the powder does not easily move according to the movement of the oil phase. As a result, the adhesion maintenance between the skin and the composition is enhanced, and from the characteristics of the water-in-oil dosage form, it exhibits remarkable resistance against water-based inhibiting factors such as sweat.
(2)本発明の皮膚外用剤
本発明の皮膚外用剤は、前記必須成分であるN−アシルアミノ酸塩を含有する被覆層を有する粉体を含有し、油中水乳化剤形であることを特徴とする。油中水乳化剤形としては、従来知られている製剤技術を応用することが出来る。即ち、有機変性ヘクトライトのような4級アミン塩で有機変性させたモンモリロナイトと多価アルコールのゲル構造を利用する方法、油脂と12−ヒドロキシステアリン酸乃至はその重合体の作る抱水性油性ゲル構造を利用する方法、アクリル−シリコーン系グラフト共重合体の作る網目構造の中に水相を詰め込む方法などが好適に例示できる。これらを複数組み合わせても安定な油中水乳化物を形成させることが出来る。
(2) External preparation for skin of the present invention The external preparation for skin of the present invention contains a powder having a coating layer containing the N-acylamino acid salt, which is the essential component, and is in the form of a water-in-oil emulsifier. And As the water-in-oil emulsifier form, conventionally known formulation techniques can be applied. That is, a method using a gel structure of montmorillonite and a polyhydric alcohol which is organically modified with a quaternary amine salt such as organically modified hectorite, a water-soluble oily gel structure formed by fat and oil and 12-hydroxystearic acid or a polymer thereof. And a method of stuffing an aqueous phase into a network structure formed by an acrylic-silicone graft copolymer. Even when a plurality of these are combined, a stable water-in-oil emulsion can be formed.
4級アミン塩で有機変性させたモンモリロナイトを利用する方法は、4級アミン塩で有機変性させたモンモリロナイトを0.3〜5質量%を用い、これにグリセリンや1,3−ブタンジオールなどの多価アルコール乃至はポリアルキレンオキシド変性シリコーンを、その1〜10質量倍、助剤として用い、乳化する技術であり、前記4級アミン塩で有機変性させたモンモリロナイトとしては、レオックス社製の「ベントンー38V」(ジメチルジステアリルアンモニウムクロリド変性ヘクトライト)が好適な市販品として例示できる。 The method of using montmorillonite organically modified with a quaternary amine salt uses 0.3 to 5% by mass of montmorillonite organically modified with a quaternary amine salt, and a glycerin, 1,3-butanediol or the like. This is a technique of emulsifying a monohydric alcohol or polyalkylene oxide-modified silicone 1 to 10 times its mass as an auxiliary agent. As montmorillonite organically modified with the quaternary amine salt, “Benton 38V” manufactured by Leox Co., Ltd. is used. (Dimethyl distearyl ammonium chloride modified hectorite) can be exemplified as a suitable commercial product.
12−ヒドロキシステアリン酸乃至はその重合体を利用する方法は、12−ヒドロキシステアリン酸乃至はその重合体を1〜5質量%と、所望により、ポリグリセリンの脂肪酸エステルを助剤として1〜5質量を用い、乳化する技術である。12−ヒドロキシステアリン酸の重合体に代えて、ポリ12−ヒドロキシステアリン酸ポリオキシエチレン付加物(例えば、ユニケマ社製の「アラセルP−135」等)を利用することも出来る。 The method using 12-hydroxystearic acid or a polymer thereof is 1 to 5% by mass of 12-hydroxystearic acid or a polymer thereof, and optionally 1 to 5 mass by using a fatty acid ester of polyglycerol as an auxiliary. Is a technique for emulsifying. Instead of the polymer of 12-hydroxystearic acid, a poly-12-hydroxystearic acid polyoxyethylene adduct (for example, “Aracel P-135” manufactured by Unikema Co., Ltd.) can be used.
アクリル−シリコーン系グラフト共重合体を用いる方法は、アクリル−シリコーン系グラフト共重合体1〜10質量%と油相とで構造を作製し、所望により、ポリグリセリン脂肪酸エステルやポリオキシアルキレン変性シリコーン1〜10質量%を助剤に用い、乳化する技術である。この様なアクリル−シリコーン系グラフト共重合体としては、信越化学工業株式会社製の「シリコーンKP−545」等が好適に例示できる。かかるアクリル−シリコーン系グラフト共重合体は、別称アクリル変性シリコーンとも称する。 In the method using an acrylic-silicone graft copolymer, a structure is prepared from 1 to 10% by mass of an acrylic-silicone graft copolymer and an oil phase, and if desired, polyglycerin fatty acid ester or polyoxyalkylene-modified silicone 1 This is a technique for emulsifying by using 10% by mass to 10% by mass as an auxiliary. As such an acryl-silicone graft copolymer, “silicone KP-545” manufactured by Shin-Etsu Chemical Co., Ltd. can be preferably exemplified. Such an acrylic-silicone graft copolymer is also referred to as an acrylic modified silicone.
その他、ジグリセリンのモノエステルやトリグリセリンのジエステルと、マルチトール、ソルビトールなどの糖類とを組み合わせて形成する油中水乳化系なども存し、この様な油中水乳化系も本発明の油中水乳化剤形の例外には当たらない。 In addition, there are water-in-oil emulsification systems formed by combining diglycerin monoesters and triglycerin diesters with sugars such as maltitol and sorbitol, and such water-in-oil emulsification systems are also oils of the present invention. There is no exception to the medium water emulsifier type.
本発明の皮膚外用剤としては、皮膚に外用で投与されるものであれば特段の限定無く適用でき、例えば、医薬部外品を包含する化粧料、皮膚外用医薬、皮膚外用雑貨等が好適に例示でき、化粧料が特に好適に例示でき、中でも、メークアップ化粧料が特に好適に例示できる。メークアップ化粧料としては、アンダーメークアップ、ファンデーション、チークカラー、アイカラー、マスカラ、アイライナー、スポッツカバー、ハイライト等が好適に例示できる。これらの中では、特に化粧映え効果の高いファンデーションが特に好適に例示できる。これは粉体の光学効果を長時間維持できると言う、本発明の効果が遺憾なく発揮できるためである。 The topical skin preparation of the present invention can be applied without particular limitation as long as it is externally administered to the skin. For example, cosmetics including quasi-drugs, external medicines for skin, sundries for skin, etc. are suitable. It can be exemplified, and cosmetics can be particularly preferably exemplified. Among them, makeup cosmetics can be particularly suitably exemplified. As makeup cosmetics, under makeup, foundation, cheek color, eye color, mascara, eyeliner, spot cover, highlight and the like can be suitably exemplified. Among these, a foundation having a particularly high cosmetic effect can be particularly preferably exemplified. This is because the optical effect of the powder can be maintained for a long time because the effect of the present invention can be exhibited without regret.
本発明の皮膚外用剤には、前記の必須成分以外に、通常化粧料などの皮膚外用剤で使用される任意成分を含有することが出来る。この様な任意成分としては、例えば、マカデミアナッツ油、アボガド油、トウモロコシ油、オリーブ油、ナタネ油、ゴマ油、ヒマシ油、サフラワー油、綿実油、ホホバ油、ヤシ油、パーム油、液状ラノリン、硬化ヤシ油、硬化油、モクロウ、硬化ヒマシ油、ミツロウ、キャンデリラロウ、カルナウバロウ、イボタロウ、ラノリン、還元ラノリン、硬質ラノリン、ホホバロウ等のオイル、ワックス類;流動パラフィン、スクワラン、プリスタン、オゾケライト、パラフィン、セレシン、ワセリン、マイクロクリスタリンワックス等の炭化水素類;オレイン酸、イソステアリン酸、ラウリン酸、ミリスチン酸、パルミチン酸、ステアリン酸、ベヘン酸、ウンデシレン酸等の高級脂肪酸類;セチルアルコール、ステアリルアルコール、イソステアリルアルコール、ベヘニルアルコール、オクチルドデカノール、ミリスチルアルコール、セトステアリルアルコール等の高級アルコール等;イソオクタン酸セチル、ミリスチン酸イソプロピル、イソステアリン酸ヘキシルデシル、アジピン酸ジイソプロピル、セバチン酸ジ−2−エチルヘキシル、乳酸セチル、リンゴ酸ジイソステアリル、ジ−2−エチルヘキサン酸エチレングリコール、ジカプリン酸ネオペンチルグリコール、ジ−2−ヘプチルウンデカン酸グリセリン、トリ−2−エチルヘキサン酸グリセリン、トリ−2−エチルヘキサン酸トリメチロールプロパン、トリイソステアリン酸トリメチロールプロパン、テトラ−2−エチルヘキサン酸ペンタンエリトリット等の合成エステル油類;ジメチルポリシロキサン、メチルフェニルポリシロキサン、ジフェニルポリシロキサン等の鎖状ポリシロキサン;オクタメチルシクロテトラシロキサン、デカメチルシクロペンタシロキサン、ドデカメチルシクロヘキサンシロキサン等の環状ポリシロキサン;アミノ変性ポリシロキサン、ポリエーテル変性ポリシロキサン、アルキル変性ポリシロキサン、フッ素変性ポリシロキサン等の変性ポリシロキサン等のシリコーン油等の油剤類;脂肪酸セッケン(ラウリン酸ナトリウム、パルミチン酸ナトリウム等)、ラウリル硫酸カリウム、アルキル硫酸トリエタノールアミンエーテル等のアニオン界面活性剤類;塩化ステアリルトリメチルアンモニウム、塩化ベンザルコニウム、ラウリルアミンオキサイド等のカチオン界面活性剤類;イミダゾリン系両性界面活性剤(2−ココイル−2−イミダゾリニウムヒドロキサイド−1−カルボキシエチロキシ2ナトリウム塩等)、ベタイン系界面活性剤(アルキルベタイン、アミドベタイン、スルホベタイン等)、アシルメチルタウリン等の両性界面活性剤類;ソルビタン脂肪酸エステル類(ソルビタンモノステアレート、セスキオレイン酸ソルビタン等)、グリセリン脂肪酸類(モノステアリン酸グリセリン等)、プロピレングリコール脂肪酸エステル類(モノステアリン酸プロピレングリコール等)、硬化ヒマシ油誘導体、グリセリンアルキルエーテル、POEソルビタン脂肪酸エステル類(POEソルビタンモノオレエート、モノステアリン酸ポリオキエチレンソルビタン等)、POEソルビット脂肪酸エステル類(POE−ソルビットモノラウレート等)、POEグリセリン脂肪酸エステル類(POE−グリセリンモノイソステアレート等)、POE脂肪酸エステル類(ポリエチレングリコールモノオレート、POEジステアレート等)、POEアルキルエーテル類(POE2−オクチルドデシルエーテル等)、POEアルキルフェニルエーテル類(POEノニルフェニルエーテル等)、プルロニック型類、POE・POPアルキルエーテル類(POE・POP2−デシルテトラデシルエーテル等)、テトロニック類、POEヒマシ油・硬化ヒマシ油誘導体(POEヒマシ油、POE硬化ヒマシ油等)、ショ糖脂肪酸エステル、アルキルグルコシド等の非イオン界面活性剤類;ポリエチレングリコール、グリセリン、1,3−ブチレングリコール、エリスリトール、ソルビトール、キシリトール、マルチトール、プロピレングリコール、ジプロピレングリコール、ジグリセリン、イソプレングリコール、1,2−ペンタンジオール、2,4−ヘキサンジオール、1,2−ヘキサンジオール、1,2−オクタンジオール等の多価アルコール類;ピロリドンカルボン酸ナトリウム、乳酸、乳酸ナトリウム等の保湿成分類;表面を処理されていても良い、マイカ、タルク、カオリン、合成雲母、炭酸カルシウム、炭酸マグネシウム、無水ケイ酸(シリカ)、酸化アルミニウム、硫酸バリウム等の粉体類、;表面を処理されていても良い、ベンガラ、黄酸化鉄、黒酸化鉄、酸化コバルト、群青、紺青、酸化チタン、酸化亜鉛の無機顔料類;表面を処理されていても良い、雲母チタン、魚燐箔、オキシ塩化ビスマス等のパール剤類;レーキ化されていても良い赤色202号、赤色228号、赤色226号、黄色4号、青色404号、黄色5号、赤色505号、赤色230号、赤色223号、橙色201号、赤色213号、黄色204号、黄色203号、青色1号、緑色201号、紫色201号、赤色204号等の有機色素類;ポリエチレン末、ポリメタクリル酸メチル、ナイロン粉末、オルガノポリシロキサンエラストマー等の有機粉体類;パラアミノ安息香酸系紫外線吸収剤;アントラニル酸系紫外線吸収剤;サリチル酸系紫外線吸収剤、;桂皮酸系紫外線吸収剤、;ベンゾフェノン系紫外線吸収剤;糖系紫外線吸収剤;2−(2’−ヒドロキシ−5’−t−オクチルフェニル)ベンゾトリアゾール、4−メトキシ−4’−t−ブチルジベンゾイルメタン等の紫外線吸収剤類;エタノール、イソプロパノール等の低級アルコール類;ビタミンA又はその誘導体、ビタミンB6塩酸塩、ビタミンB6トリパルミテート、ビタミンB6ジオクタノエート、ビタミンB2又はその誘導体、ビタミンB12、ビタミンB15又はその誘導体等のビタミンB類;α−トコフェロール、β−トコフェロール、γ−トコフェロール、ビタミンEアセテート等のビタミンE類、ビタミンD類、ビタミンH、パントテン酸、パンテチン、ピロロキノリンキノン等のビタミン類等;フェノキシエタノール等の抗菌剤などが好ましく例示できる。 The external preparation for skin of the present invention can contain optional components that are usually used in external preparations for skin such as cosmetics, in addition to the essential components described above. Such optional ingredients include, for example, macadamia nut oil, avocado oil, corn oil, olive oil, rapeseed oil, sesame oil, castor oil, safflower oil, cottonseed oil, jojoba oil, coconut oil, palm oil, liquid lanolin, hydrogenated coconut oil Oil, wax, oils such as beeswax, owl, hydrogenated castor oil, beeswax, candelilla wax, carnauba wax, ibotarou, lanolin, reduced lanolin, hard lanolin, jojoba wax; liquid paraffin, squalane, pristane, ozokerite, paraffin, ceresin, petrolatum , Hydrocarbons such as microcrystalline wax; higher fatty acids such as oleic acid, isostearic acid, lauric acid, myristic acid, palmitic acid, stearic acid, behenic acid, undecylenic acid; cetyl alcohol, stearyl alcohol, isostearyl Higher alcohols such as alcohol, behenyl alcohol, octyldodecanol, myristyl alcohol, cetostearyl alcohol; cetyl isooctanoate, isopropyl myristate, hexyldecyl isostearate, diisopropyl adipate, di-2-ethylhexyl sebacate, cetyl lactate, malic acid Diisostearyl, di-2-ethylhexanoic acid ethylene glycol, dicaprate neopentyl glycol, di-2-heptylundecanoic acid glycerin, tri-2-ethylhexanoic acid glycerin, tri-2-ethylhexanoic acid trimethylolpropane, tri Synthetic ester oils such as trimethylolpropane isostearate and pentane erythritol tetra-2-ethylhexanoate; dimethylpolysiloxane, methylphenylpoly Linear polysiloxanes such as oxane and diphenylpolysiloxane; cyclic polysiloxanes such as octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane, and dodecamethylcyclohexanesiloxane; amino-modified polysiloxane, polyether-modified polysiloxane, alkyl-modified polysiloxane, Oil agents such as silicone oils such as modified polysiloxanes such as fluorine-modified polysiloxanes; Anionic surfactants such as fatty acid soap (sodium laurate, sodium palmitate, etc.), potassium lauryl sulfate, triethanolamine ether of alkyl sulfates; Cationic surfactants such as stearyltrimethylammonium, benzalkonium chloride, laurylamine oxide; imidazoline-based amphoteric surfactants (2-cocoyl-2-imida Zolinium hydroxide-1-carboxyethyloxy disodium salt, etc.), betaine surfactants (alkyl betaine, amide betaine, sulfobetaine, etc.), and amphoteric surfactants such as acylmethyltaurine; sorbitan fatty acid esters (sorbitan) Monostearate, sorbitan sesquioleate, etc.), glycerin fatty acids (eg, glyceryl monostearate), propylene glycol fatty acid esters (eg, propylene glycol monostearate), hardened castor oil derivatives, glycerin alkyl ethers, POE sorbitan fatty acid esters (POE sorbitan monooleate, polyoxyethylene sorbitan monostearate, etc.), POE sorbite fatty acid esters (POE-sorbitol monolaurate, etc.), POE glycerin fatty acid ester Tells (POE-glycerol monoisostearate, etc.), POE fatty acid esters (polyethylene glycol monooleate, POE distearate, etc.), POE alkyl ethers (POE2-octyldodecyl ether, etc.), POE alkylphenyl ethers (POE nonylphenyl) Ethers, etc.), Pluronic types, POE / POP alkyl ethers (POE / POP2-decyltetradecyl ether, etc.), Tetronics, POE castor oil / hardened castor oil derivatives (POE castor oil, POE hardened castor oil, etc.), Nonionic surfactants such as sucrose fatty acid ester and alkyl glucoside; polyethylene glycol, glycerin, 1,3-butylene glycol, erythritol, sorbitol, xylitol, maltitol, propylene Polyhydric alcohols such as recall, dipropylene glycol, diglycerin, isoprene glycol, 1,2-pentanediol, 2,4-hexanediol, 1,2-hexanediol, 1,2-octanediol; sodium pyrrolidonecarboxylate Moisturizing ingredients such as lactic acid and sodium lactate; powders such as mica, talc, kaolin, synthetic mica, calcium carbonate, magnesium carbonate, anhydrous silicic acid (silica), aluminum oxide, barium sulfate, etc. whose surface may be treated Body, the surface may be treated, inorganic pigments such as bengara, yellow iron oxide, black iron oxide, cobalt oxide, ultramarine, bitumen, titanium oxide, zinc oxide; surface may be treated, mica Pearl agents such as titanium, fish phosphorus foil, bismuth oxychloride; red 202 which may be raked, red Color 228, Red 226, Yellow 4, Blue 404, Yellow 5, Red 505, Red 230, Red 223, Orange 201, Red 213, Yellow 204, Yellow 203, Blue 1 No., green 201, purple 201, red 204, etc .; organic powders such as polyethylene powder, polymethyl methacrylate, nylon powder, organopolysiloxane elastomer; para-aminobenzoic acid UV absorbers; anthranils Acid UV absorbers; salicylic acid UV absorbers; cinnamic acid UV absorbers; benzophenone UV absorbers; sugar UV absorbers; 2- (2′-hydroxy-5′-t-octylphenyl) benzo Ultraviolet absorbers such as triazole and 4-methoxy-4′-t-butyldibenzoylmethane; lower grades such as ethanol and isopropanol Alcohols; vitamin A or derivatives thereof, vitamin B6 hydrochloride, vitamin B6 tripalmitate, vitamin B6 dioctanoate, vitamin B2 or derivatives thereof, vitamin B12 such as vitamin B12, vitamin B15 or derivatives thereof; α-tocopherol, β- Preferred examples include vitamins such as tocopherol, γ-tocopherol and vitamin E acetate, vitamin D acetate, vitamin D, vitamin H, pantothenic acid, panthetin, pyrroloquinoline quinone and the like; and antibacterial agents such as phenoxyethanol.
この様な任意成分の内、本発明の皮膚外用剤に於いて特に好ましいものは、皮脂中の脂肪酸をトラップする作用を有する粉体であり、この様な粉体としては、例えば、亜鉛及び/又はアルミニウムをインターカレートしたモンモリロナイト、酸化亜鉛或いはヒドキシアパタイト被覆粉体等が好適に例示できる。亜鉛及び/又はアルミニウムをインターカレートしたモンモリロナイトとしては、下記の製造例5の如くに製造することも出来るし、既に市販されている粉体を購入して利用することも出来る。この様な市販されている粉体としては、大東化成株式会社製の「オイルセンサーパウダー」が好適に例示できる。酸化亜鉛は、化粧料などの皮膚外用剤で通常使用されているものを利用できる。所望により、ハイドロジェンメチルポリシロキサン焼付処理やシリル化剤によるシリル化処理、脂肪酸金属石鹸被覆処理などを表面に施し、使用することも出来るが、表面処理を行わない方が皮脂トラップ効果が高いので好ましい。ヒドロキシアパタイト被覆粉体は、下記製造例6の如くに調整することも出来るし、既に市販されているものを購入して使用することも出来る。好ましい市販品としては、例えば、三好化成株式会社製の「パウダー・ラ・ヴィ」(ヒドロキシアパタイト・酸化亜鉛被覆セリサイト)等が好適に例示できる。かかる皮脂中の脂肪酸をトラップする作用を有する粉体は唯一種を含有することも出来るし、二種以上を組み合わせて含有することも出来る。かかる皮脂中の脂肪酸をトラップする作用を有する粉体の好ましい含有量は、総量で、皮膚外用剤全量に対して、0.01〜5質量%であり、より好ましくは、0.05〜1質量%である。 Among such optional components, particularly preferred in the external preparation for skin of the present invention is a powder having an action of trapping fatty acids in sebum. Examples of such powder include zinc and / or Alternatively, montmorillonite intercalated with aluminum, zinc oxide, hydroxyapatite-coated powder or the like can be suitably exemplified. The montmorillonite intercalated with zinc and / or aluminum can be produced as in Production Example 5 below, or a commercially available powder can be purchased and used. As such a commercially available powder, “oil sensor powder” manufactured by Daito Kasei Co., Ltd. can be suitably exemplified. As zinc oxide, those usually used in skin external preparations such as cosmetics can be used. If desired, hydrogen methylpolysiloxane baking treatment, silylation treatment with a silylating agent, fatty acid metal soap coating treatment, etc. can be applied to the surface and used, but since the surface treatment is not performed, the sebum trapping effect is higher. preferable. The hydroxyapatite-coated powder can be prepared as in Production Example 6 below, or a commercially available product can be purchased and used. Preferable examples of commercially available products include “Powder La Vi” (hydroxyapatite / zinc oxide-coated sericite) manufactured by Miyoshi Kasei Co., Ltd. Such a powder having an action of trapping fatty acids in sebum can contain a single species or a combination of two or more species. The preferable content of the powder having an action of trapping fatty acids in the sebum is 0.01 to 5% by mass, more preferably 0.05 to 1% by mass based on the total amount of the external preparation for skin. %.
<製造例5>
0.4M硝酸アルミニウム水溶液300mlに0.4N水酸化ナトリウム水溶液400mlを滴下し60℃で6時間攪拌し透明な液を得た。これにナトリウム型モンモリロナイト6.67gを徐々に加え水333mlを加え、室温で2時間攪拌した。これを10000rpmで10分間遠心分離し上清を捨てた。更に2回500mlを加え同様に遠心分離し、不溶物を洗浄した。これを凍結乾燥し、水分を除去した。この2gを取り、0.2M硝酸亜鉛水溶液40mlを加え良く分散させ、これに0.4N水酸化ナトリウム水溶液30mlを加え良く攪拌した後、10000rpmで10分間遠心分離し上清を捨てた。更に2回500mlを加え同様に遠心分離し、不溶物を洗浄した。これを凍結乾燥させ亜鉛・アルミニウムを層間にインターカレートした粉体5を得た。
<Production Example 5>
400 ml of 0.4N sodium hydroxide aqueous solution was added dropwise to 300 ml of 0.4M aluminum nitrate aqueous solution and stirred at 60 ° C. for 6 hours to obtain a transparent liquid. To this, 6.67 g of sodium montmorillonite was gradually added, 333 ml of water was added, and the mixture was stirred at room temperature for 2 hours. This was centrifuged at 10,000 rpm for 10 minutes, and the supernatant was discarded. Further, 500 ml was added twice and centrifuged in the same manner to wash insoluble matters. This was freeze-dried to remove moisture. 2 g of this was taken and 40 ml of 0.2 M zinc nitrate aqueous solution was added and dispersed well. To this, 30 ml of 0.4 N sodium hydroxide aqueous solution was added and stirred well, then centrifuged at 10,000 rpm for 10 minutes and the supernatant was discarded. Further, 500 ml was added twice and centrifuged in the same manner to wash insoluble matters. This was freeze-dried to obtain a powder 5 in which zinc and aluminum were intercalated between layers.
<製造例6>
燐酸二アンモニウム85.2gを水4.5lに溶かして溶液とし、これにセリサイト1Kgを加え均一に分散させた。次に、攪拌冷却下、アンモニア水を徐々に添加して系のpHを9.0に調整し、硝酸カルシウム156.1gを水500mlに溶かした溶液を徐々に加えた。添加終了後、さらに1時間攪拌を続け、得られたスラリーを遠心分離(3000g、10分)し、上清を捨て、再度2lの水を加えて分散させて、遠心分離し、洗浄した。この洗浄作業は3回行った。その後、遠心分離して脱水した粉体を110℃の温度で乾燥してヒドロキシアパタイト被覆(約2質量%)セリサイト(粉体6)を得た。
<Production Example 6>
85.2 g of diammonium phosphate was dissolved in 4.5 liters of water to form a solution, and 1 kg of sericite was added thereto and dispersed uniformly. Next, with stirring and cooling, aqueous ammonia was gradually added to adjust the pH of the system to 9.0, and a solution prepared by dissolving 156.1 g of calcium nitrate in 500 ml of water was gradually added. After completion of the addition, the mixture was further stirred for 1 hour, and the resulting slurry was centrifuged (3000 g, 10 minutes). The supernatant was discarded, and 2 l of water was added again to disperse, followed by centrifugation and washing. This washing operation was performed three times. Thereafter, the dehydrated powder by centrifugation was dried at a temperature of 110 ° C. to obtain hydroxyapatite-coated (about 2 mass%) sericite (powder 6).
<製造例7>
製造例6と同様の操作で、セリサイトをマイカに置換して処理し、ヒドロキシアパタイト被覆(約2質量%)マイカ(粉体7)を得た。
<Production Example 7>
By the same operation as in Production Example 6, the sericite was replaced with mica and treated to obtain hydroxyapatite-coated (about 2% by mass) mica (powder 7).
<製造例8>
製造例6と同様の操作で、セリサイトをタルクに置換して処理し、ヒドロキシアパタイト被覆(約2質量%)タルク(粉体8)を得た。
<Production Example 8>
In the same manner as in Production Example 6, sericite was replaced with talc and treated to obtain hydroxyapatite-coated (about 2% by mass) talc (powder 8).
以上に例示した必須成分及び任意成分を常法に従って処理することにより、本発明の皮膚外用剤を製造することが出来る。以下に、実施例を示して、本発明について、更に詳細に説明を加えるが、本発明が、かかる実施例にのみ、限定されないことは言うまでもない。 The skin external preparation of this invention can be manufactured by processing the essential component and arbitrary component which were illustrated above according to the conventional method. Hereinafter, the present invention will be described in more detail with reference to examples, but it goes without saying that the present invention is not limited to such examples.
下記に示す処方に従って、本発明の皮膚外用剤である、ファンデーション(メークアップ化粧料)を作製した。即ち、イ、ロ、ハの成分を80℃に温度調整し、イを混練りした後に、これにロの成分を加えて希釈し、これにニの成分を加え、ディスパーで一様に分散させ、攪拌下徐々にハの成分を加えて乳化し、攪拌冷却して油中水乳化剤形の化粧料1を得た。粉体1を二酸化チタンに、粉体2をベンガラに、粉体3を黄色酸化鉄に、粉体4をタルクに置換した比較例1、粉体1をハイドロジェンメチルポリシロキサン5%焼付処理した二酸化チタンに、粉体2をハイドロジェンメチルポリシロキサン5%焼付処理したベンガラに、粉体3をハイドロジェンメチルポリシロキサン5%焼付処理した黄色酸化鉄に、粉体4をハイドロジェンメチルポリシロキサン5%焼付処理したタルクに置換した比較例2も同様に製造した。尚、比較例1は製造直後に肉眼で確認できる程度の色剤の分散むらが存した。 In accordance with the formulation shown below, a foundation (makeup cosmetic), which is an external preparation for skin of the present invention, was prepared. That is, after adjusting the temperature of the components of A, B, and C to 80 ° C. and kneading A, add the component of B and dilute it, add the component of D to this, and disperse it uniformly with a disper. Under stirring, the component C was gradually added to emulsify, and stirred and cooled to obtain a water-in-oil emulsifier type cosmetic 1. Comparative Example 1 in which the powder 1 was replaced with titanium dioxide, the powder 2 with bengara, the powder 3 with yellow iron oxide, and the powder 4 with talc, and the powder 1 was baked with 5% hydrogen methylpolysiloxane. Tungsten dioxide, Bengala powder 5 treated with 5% hydrogenmethylpolysiloxane, powder 3 coated with yellow iron oxide 5% treated with hydrogenmethylpolysiloxane, powder 4 treated with hydrogenmethylpolysiloxane 5 A comparative example 2 in which the baked talc was replaced with a% baking was also produced in the same manner. In Comparative Example 1, there was uneven dispersion of the colorant that could be confirmed with the naked eye immediately after production.
<試験例1>
上腕内側部に2cm×4cmの部位を3つ設け、1つの部位には化粧料1を40μl塗布し、1の部位には比較例1を40μl塗布し、残る1つの部位には比較例2を40μl塗布した。塗布後15分にコニカミノルタ色彩色差計CR400にて、部位と標準白色板との色差を計測し、その後4時間普通に生活し、再度標準白色板との色差を計測した。この測定データより、化粧料塗布直後と4時間後の色差(ΔE)を算出した。結果を表2に示す。
<Test Example 1>
Three parts of 2 cm × 4 cm are provided on the inner side of the upper arm, 40 μl of cosmetic 1 is applied to one part, 40 μl of Comparative Example 1 is applied to one part, and Comparative Example 2 is applied to the remaining part. 40 μl was applied. 15 minutes after application, the Konica Minolta color difference meter CR400 was used to measure the color difference between the site and the standard white plate, and then the normal color was measured for 4 hours, and the color difference from the standard white plate was measured again. From this measurement data, the color difference (ΔE) immediately after the cosmetic application and after 4 hours was calculated. The results are shown in Table 2.
<試験例2>
試験例1の変化条件を4時間の通常生活条件から、流温水下30秒被曝に代えて同様の検討を行った。結果を表3に示す。これより、シリコーン処理は耐水性には顕著な向上効果を示すが、通常の条件では耐水性ほど接着性維持効果を奏していないことがわかる。このことは、皮膚との接着性維持性の向上には、粉体の耐水性向上以上の因子が存することが推定される。又、N−アシルアミノ酸塩を含有する被覆層を有する粉体は、耐水性も、通常生活条件でも顕著な皮膚との接着維持性を有していることが確認された。
<Test Example 2>
The change conditions of Test Example 1 were changed from normal living conditions of 4 hours to 30 seconds exposure under flowing hot water, and the same examination was performed. The results are shown in Table 3. From this, it can be seen that the silicone treatment shows a remarkable improvement effect on water resistance, but under normal conditions, it does not have the effect of maintaining adhesion as much as water resistance. From this, it is presumed that a factor more than the improvement of the water resistance of the powder exists in the improvement of the adhesiveness maintenance property with the skin. Moreover, it was confirmed that the powder having a coating layer containing an N-acylamino acid salt has water resistance and remarkable adhesion maintenance with the skin even under normal living conditions.
実施例1と同様に操作して、本発明の皮膚外用剤である、化粧料2を得た。このものを試験例1の方法で評価したところ、4時間の通常条件被曝下の色差(ΔE)は0.35であり、皮脂トラップ能を有する粉体を含有することが好ましいことがわかった。 By operating in the same manner as in Example 1, a cosmetic 2 as an external preparation for skin of the present invention was obtained. When this was evaluated by the method of Test Example 1, it was found that the color difference (ΔE) under exposure under normal conditions for 4 hours was 0.35, and it was preferable to contain a powder having sebum trapping ability.
下記に示す処方に従って、実施例1と同様に操作して、化粧料3〜6を作製した。これらの化粧料を試験例1の方法に従って、評価した結果を表6に示す。これより、何れの皮脂トラップ能を有する粉体はその効果を奏することがわかる。 According to the formulation shown below, cosmetics 3 to 6 were produced in the same manner as in Example 1. The results of evaluating these cosmetics according to the method of Test Example 1 are shown in Table 6. From this, it is understood that any powder having sebum trapping ability has the effect.
下記の処方に従って、実施例1と同様に操作して、化粧料7を作製した。このものは試験例1の評価で色差(ΔE)は0.06であった。 A cosmetic 7 was prepared in the same manner as in Example 1 according to the following prescription. This product was evaluated in Test Example 1 and the color difference (ΔE) was 0.06.
実施例1と同様に、下記の処方に従って、化粧料8を作製した。このものは、試験例1の評価において、色差(ΔE)は0.21であった。更に、驚くべきことに、乳化型のファンデーションでは粉体の配合上限値は30質量%程度と言われているのに対し、この化粧料の粉体含有量は40%を越えるものであった。粉体を比較例2の如くにハイドロジェンメチルポリシロキサン処理粉体に置換したところ、分散途中に固化し、製造不能になった。粉体を多量に含有できることも本発明の効果であると思われる。 In the same manner as in Example 1, cosmetic 8 was prepared according to the following formulation. This product had a color difference (ΔE) of 0.21 in the evaluation of Test Example 1. Furthermore, surprisingly, in the emulsification type foundation, the upper limit value of the powder is said to be about 30% by mass, whereas the powder content of this cosmetic exceeds 40%. When the powder was replaced with hydrogenmethylpolysiloxane-treated powder as in Comparative Example 2, it became solidified during dispersion and became unmanufacturable. The fact that a large amount of powder can be contained is considered to be an effect of the present invention.
以下に示す処方に従って、実施例1と同様に化粧料9を作製した。このものは、試験例1の評価において、色差(ΔE)は0.19であった。 A cosmetic 9 was prepared in the same manner as in Example 1 according to the formulation shown below. This product had a color difference (ΔE) of 0.19 in the evaluation of Test Example 1.
以下に示す処方に従って、実施例1と同様に化粧料10を作製した。このものは、試験例1の評価において、色差(ΔE)は0.24であった。 A cosmetic 10 was prepared in the same manner as in Example 1 according to the formulation shown below. This product had a color difference (ΔE) of 0.24 in the evaluation of Test Example 1.
本発明は、化粧料などの皮膚外用剤の応用できる。 The present invention can be applied to skin external preparations such as cosmetics.
Claims (8)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2007144519A JP2008297238A (en) | 2007-05-31 | 2007-05-31 | Water-in-oil emulsion type powder-containing external preparation for skin |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2007144519A JP2008297238A (en) | 2007-05-31 | 2007-05-31 | Water-in-oil emulsion type powder-containing external preparation for skin |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008297238A true JP2008297238A (en) | 2008-12-11 |
| JP2008297238A5 JP2008297238A5 (en) | 2010-07-01 |
Family
ID=40171084
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007144519A Pending JP2008297238A (en) | 2007-05-31 | 2007-05-31 | Water-in-oil emulsion type powder-containing external preparation for skin |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2008297238A (en) |
Cited By (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2013525459A (en) * | 2010-05-07 | 2013-06-20 | ユニリーバー・ナームローゼ・ベンノートシヤープ | Skin conditioning composition containing 12-hydroxystearic acid |
| WO2013153174A1 (en) * | 2012-04-11 | 2013-10-17 | Sensient Cosmetic Technologies | Pigment composition containing amino acid derivatives, and cosmetic uses of said pigment composition |
| JP2013542232A (en) * | 2010-11-11 | 2013-11-21 | ユニリーバー・ナームローゼ・ベンノートシヤープ | Leave-on type non-solid skin conditioning composition containing 12-[(12-hydroxyoctadecanoyl) oxy] octadecanoic acid |
| CN104693060A (en) * | 2014-12-08 | 2015-06-10 | 九江天赐高新材料有限公司 | Preparation method of N-lauroyl-glutamate sodium |
| CN104693061A (en) * | 2015-03-26 | 2015-06-10 | 南通市明建生物科技有限公司 | Method for preparing N-fatty acyl group amino acid compound |
| JP2016222587A (en) * | 2015-05-29 | 2016-12-28 | 株式会社日本色材工業研究所 | Water-in-oil emulsion cosmetic |
| JP2018070516A (en) * | 2016-10-31 | 2018-05-10 | 花王株式会社 | Water-in-oil emulsion cosmetic |
| JP2018177736A (en) * | 2017-04-20 | 2018-11-15 | 株式会社日本色材工業研究所 | Water-in-oil emulsified cosmetic |
| JP2022021496A (en) * | 2020-07-22 | 2022-02-03 | ポーラ化成工業株式会社 | Water-in-oil emulsification composition |
| JP2022077263A (en) * | 2020-11-11 | 2022-05-23 | 株式会社 資生堂 | Cosmetic |
| JP2022096403A (en) * | 2020-12-17 | 2022-06-29 | 花王株式会社 | Water-in-oil emulsified solid cosmetic |
Citations (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH09268120A (en) * | 1996-04-03 | 1997-10-14 | Pola Chem Ind Inc | Water-in-oil type emulsified composition |
| JPH1087420A (en) * | 1996-09-12 | 1998-04-07 | Pola Chem Ind Inc | Intercalation metal clathrate compound |
| JPH10212223A (en) * | 1997-01-29 | 1998-08-11 | Shiseido Co Ltd | Cosmetic |
| JP2000212041A (en) * | 1998-11-17 | 2000-08-02 | Miyoshi Kasei Kk | New coated powder and cosmetic formulating the same therein |
| JP2002047129A (en) * | 2000-08-02 | 2002-02-12 | Kose Corp | Emulsified cosmetic |
| JP2004026794A (en) * | 2002-06-25 | 2004-01-29 | Miyoshi Kasei Inc | Pigment dispersion and cosmetic containing the same |
| JP2004210765A (en) * | 2002-11-14 | 2004-07-29 | Kose Corp | Oil in water type emulsified cosmetic |
| JP2004315467A (en) * | 2003-04-18 | 2004-11-11 | Miyoshi Kasei Inc | Sebum adsorbing powder and use thereof |
| WO2005082320A1 (en) * | 2004-02-26 | 2005-09-09 | The Procter & Gamble Company | Make-up composition |
| JP2005255623A (en) * | 2004-03-12 | 2005-09-22 | Kanebo Cosmetics Inc | Water-in-oil foundation |
| JP2005298385A (en) * | 2004-04-09 | 2005-10-27 | L'oreal Sa | Cosmetic composition containing surface-modified pearlescent pigment |
| JP2007039372A (en) * | 2005-08-03 | 2007-02-15 | Pola Chem Ind Inc | Cosmetic suitable for correction of pore |
| JP2007045772A (en) * | 2005-08-11 | 2007-02-22 | Pola Chem Ind Inc | Cosmetic product for summer season |
| WO2007032937A1 (en) * | 2005-09-09 | 2007-03-22 | The Procter & Gamble Company | Solid skin care composition comprising multiple layers based on water-in-oil emulsions |
-
2007
- 2007-05-31 JP JP2007144519A patent/JP2008297238A/en active Pending
Patent Citations (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH09268120A (en) * | 1996-04-03 | 1997-10-14 | Pola Chem Ind Inc | Water-in-oil type emulsified composition |
| JPH1087420A (en) * | 1996-09-12 | 1998-04-07 | Pola Chem Ind Inc | Intercalation metal clathrate compound |
| JPH10212223A (en) * | 1997-01-29 | 1998-08-11 | Shiseido Co Ltd | Cosmetic |
| JP2000212041A (en) * | 1998-11-17 | 2000-08-02 | Miyoshi Kasei Kk | New coated powder and cosmetic formulating the same therein |
| JP2002047129A (en) * | 2000-08-02 | 2002-02-12 | Kose Corp | Emulsified cosmetic |
| JP2004026794A (en) * | 2002-06-25 | 2004-01-29 | Miyoshi Kasei Inc | Pigment dispersion and cosmetic containing the same |
| JP2004210765A (en) * | 2002-11-14 | 2004-07-29 | Kose Corp | Oil in water type emulsified cosmetic |
| JP2004315467A (en) * | 2003-04-18 | 2004-11-11 | Miyoshi Kasei Inc | Sebum adsorbing powder and use thereof |
| WO2005082320A1 (en) * | 2004-02-26 | 2005-09-09 | The Procter & Gamble Company | Make-up composition |
| JP2005255623A (en) * | 2004-03-12 | 2005-09-22 | Kanebo Cosmetics Inc | Water-in-oil foundation |
| JP2005298385A (en) * | 2004-04-09 | 2005-10-27 | L'oreal Sa | Cosmetic composition containing surface-modified pearlescent pigment |
| JP2007039372A (en) * | 2005-08-03 | 2007-02-15 | Pola Chem Ind Inc | Cosmetic suitable for correction of pore |
| JP2007045772A (en) * | 2005-08-11 | 2007-02-22 | Pola Chem Ind Inc | Cosmetic product for summer season |
| WO2007032937A1 (en) * | 2005-09-09 | 2007-03-22 | The Procter & Gamble Company | Solid skin care composition comprising multiple layers based on water-in-oil emulsions |
Cited By (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2013525459A (en) * | 2010-05-07 | 2013-06-20 | ユニリーバー・ナームローゼ・ベンノートシヤープ | Skin conditioning composition containing 12-hydroxystearic acid |
| US9539190B2 (en) | 2010-05-07 | 2017-01-10 | Conopco, Inc. | Skin conditioning compositions containing 12-hydroxystearic acid |
| JP2013542232A (en) * | 2010-11-11 | 2013-11-21 | ユニリーバー・ナームローゼ・ベンノートシヤープ | Leave-on type non-solid skin conditioning composition containing 12-[(12-hydroxyoctadecanoyl) oxy] octadecanoic acid |
| WO2013153174A1 (en) * | 2012-04-11 | 2013-10-17 | Sensient Cosmetic Technologies | Pigment composition containing amino acid derivatives, and cosmetic uses of said pigment composition |
| FR2989269A1 (en) * | 2012-04-11 | 2013-10-18 | Sensient Cosmetic Technologies | PIGMENT COMPOSITION COMPRISING AMINO ACID DERIVATIVES AND COSMETIC USES |
| CN104693060A (en) * | 2014-12-08 | 2015-06-10 | 九江天赐高新材料有限公司 | Preparation method of N-lauroyl-glutamate sodium |
| CN104693061A (en) * | 2015-03-26 | 2015-06-10 | 南通市明建生物科技有限公司 | Method for preparing N-fatty acyl group amino acid compound |
| JP2016222587A (en) * | 2015-05-29 | 2016-12-28 | 株式会社日本色材工業研究所 | Water-in-oil emulsion cosmetic |
| JP2018070516A (en) * | 2016-10-31 | 2018-05-10 | 花王株式会社 | Water-in-oil emulsion cosmetic |
| JP7067860B2 (en) | 2016-10-31 | 2022-05-16 | 花王株式会社 | Manufacturing method of water-based emulsified cosmetics in oil |
| JP2022093518A (en) * | 2016-10-31 | 2022-06-23 | 花王株式会社 | Water-in-oil emulsified cosmetics |
| JP2018177736A (en) * | 2017-04-20 | 2018-11-15 | 株式会社日本色材工業研究所 | Water-in-oil emulsified cosmetic |
| JP6990035B2 (en) | 2017-04-20 | 2022-01-12 | 株式会社日本色材工業研究所 | Water-in-oil emulsified cosmetic |
| JP2022021496A (en) * | 2020-07-22 | 2022-02-03 | ポーラ化成工業株式会社 | Water-in-oil emulsification composition |
| JP2022077263A (en) * | 2020-11-11 | 2022-05-23 | 株式会社 資生堂 | Cosmetic |
| JP7709276B2 (en) | 2020-11-11 | 2025-07-16 | 株式会社 資生堂 | Cosmetics |
| JP2022096403A (en) * | 2020-12-17 | 2022-06-29 | 花王株式会社 | Water-in-oil emulsified solid cosmetic |
| JP7796476B2 (en) | 2020-12-17 | 2026-01-09 | 花王株式会社 | Water-in-oil emulsion solid cosmetics |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008297238A (en) | Water-in-oil emulsion type powder-containing external preparation for skin | |
| JP6887765B2 (en) | Sunscreen cosmetics | |
| JP6359295B2 (en) | Water-in-oil emulsified cosmetic and method for producing the same | |
| JP2010168302A (en) | Emulsified cosmetic | |
| JP6640520B2 (en) | Oil-in-water emulsion composition | |
| JPWO2017188279A1 (en) | Cosmetic composition and cosmetics containing the same | |
| JP2008297239A (en) | Water-in-oil type external preparation for skin | |
| JP2008143837A (en) | Powder-containing cosmetic | |
| JP5201658B2 (en) | Multi-layer treated powder-containing aqueous skin preparation | |
| JP2009155243A5 (en) | ||
| JP2008019230A5 (en) | ||
| JP2008143837A5 (en) | ||
| JP2009155243A (en) | Powdered emulsifier type skin external preparation | |
| JP2008143836A (en) | Surface-treated powder and cosmetic containing the surface-treated powder | |
| JP2008255044A5 (en) | ||
| JP2008297240A (en) | Solid powder cosmetic | |
| JP2010030933A (en) | Skin care preparation for external use | |
| JP5491742B2 (en) | Makeup cosmetics | |
| JP2009155241A5 (en) | ||
| JP2007308385A5 (en) | ||
| JP2010030932A (en) | Skin care preparation for external use | |
| JP2007308384A5 (en) | ||
| JP2008120757A (en) | Emulsified skin external preparation containing powder treated with hydroxyapatite | |
| JP2008120757A5 (en) | ||
| JP2007308381A5 (en) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Written amendment |
Effective date: 20100517 Free format text: JAPANESE INTERMEDIATE CODE: A523 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20100517 |
|
| RD03 | Notification of appointment of power of attorney |
Effective date: 20100517 Free format text: JAPANESE INTERMEDIATE CODE: A7423 |
|
| A977 | Report on retrieval |
Effective date: 20120120 Free format text: JAPANESE INTERMEDIATE CODE: A971007 |
|
| A131 | Notification of reasons for refusal |
Effective date: 20120221 Free format text: JAPANESE INTERMEDIATE CODE: A131 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20120619 |